IV Spanish Consensus Conference on Helicobacter pylori infection treatment

Gisbert, JP; Molina-Infante, J; Amador, J; Bermejo, F; Bujanda, L; Calvet, X; Castro-Fernández, M; Cuadrado-Lavín, A; Elizalde, JI; Gene, E; Gomollón, F; Lanas, Á; Martín de Argila, C; Mearin, F; Montoro, M; Pérez-Aisa, Á; Pérez-Trallero, E; McNicholl, AG.

Gastroenterol. hepatol; 39 (10), 2016

Helicobacter pylori approximately infect 50% of Spanish population and causes chronic gastritis, peptic ulcer and gastric cancer. Until now, three consensus meetings on H.pylori infection had been performed in Spain (the last in 2012). The changes in the treatment schemes, and the increasing available ev...

Antibacterianos/uso terapéutico, Inhibidores de la Bomba de Protones/uso terapéutico, Bismuto/uso terapéutico, Algoritmos, Técnica Delfos, Quimioterapia Combinada, Gastritis/complicaciones, Infecciones por Helicobacter, Helicobacter pylori, Probióticos, Inhibidores de la Bomba de Protones, Recurrencia, Terapia Recuperativa, Neoplasias Gástricas, Úlcera Gástrica, Insuficiencia del Tratamiento, Gastritis/tratamiento farmacológico, Infecciones por Helicobacter/tratamiento farmacológico, Helicobacter pylori/efectos de los fármacos

Texto completo

Joint ESPGHAN/NASPGHAN guidelines for the management of helicobacter pylori in children and adolescents (Update 2016)

BACKGROUND: Because of the changing epidemiology of Helicobacter pylori infection and low efficacy of currently recommended therapies, an update of the European Society for Paediatric Gastroenterology Hepatology and Nutrition/North American Society for Pediatric Gastroenterology, Hepatology and Nutrition...